Search research articles
Contact Us
Filters
Showing results (881-890 of 992) with videos related to
Page
of 100
Sort By:
Nature Medicine
|
July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model
Malick M Gibani, Elizabeth Jones, Amber Barton, et al.
The Pediatric Infectious Disease Journal
|
July 22, 2021
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers
Meeru Gurung, Sanjeev M Bijukchhe, Parisa Hariri, et al.
The Lancet. Microbe
|
June 15, 2024
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study
Sue Ann Costa Clemens, Brett Jepson, Qasim E Bhorat, et al.
Vaccine
|
December 24, 2021
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis
Blanché Oguti, Asad Ali, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model
Hazel C Dobinson, Malick M Gibani, Claire Jones, et al.
BMJ Open
|
January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol
Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The Journal of Infection
|
March 2, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
The Pediatric Infectious Disease Journal
|
December 27, 2021
Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013)
Michael J Carter, Meeru Gurung, Bhishma Pokhrel, et al.
The Journal of Pathology
|
June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Health Technology Assessment (Winchester, England)
|
September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
Hans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
Page
of 100
Search research articles
Search
Showing results (881-890 of 992) with videos related to
Sort By:
Page
of 100
Nature Medicine
|
July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model
Malick M Gibani, Elizabeth Jones, Amber Barton, et al.
The Pediatric Infectious Disease Journal
|
July 22, 2021
Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers
Meeru Gurung, Sanjeev M Bijukchhe, Parisa Hariri, et al.
The Lancet. Microbe
|
June 15, 2024
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study
Sue Ann Costa Clemens, Brett Jepson, Qasim E Bhorat, et al.
Vaccine
|
December 24, 2021
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis
Blanché Oguti, Asad Ali, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model
Hazel C Dobinson, Malick M Gibani, Claire Jones, et al.
BMJ Open
|
January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol
Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The Journal of Infection
|
March 2, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
The Pediatric Infectious Disease Journal
|
December 27, 2021
Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013)
Michael J Carter, Meeru Gurung, Bhishma Pokhrel, et al.
The Journal of Pathology
|
June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Health Technology Assessment (Winchester, England)
|
September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
Hans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
Page
of 100